Royal Bank of Canada’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-5,618
| Closed | -$63K | – | 6412 |
|
|
2017
Q3 | $63K | Buy |
5,618
+3,996
| +246% | +$44.8K | ﹤0.01% | 4559 |
|
|
2017
Q2 | $18K | Buy |
1,622
+22
| +1% | +$244 | ﹤0.01% | 4850 |
|
|
2017
Q1 | $16K | Sell |
1,600
-2,232
| -58% | -$22.3K | ﹤0.01% | 5075 |
|
|
2016
Q4 | $41K | Buy |
3,832
+2,209
| +136% | +$23.6K | ﹤0.01% | 4631 |
|
|
2016
Q3 | $16K | Sell |
1,623
-77
| -5% | -$759 | ﹤0.01% | 4878 |
|
|
2016
Q2 | $22K | Sell |
1,700
-500
| -23% | -$6.47K | ﹤0.01% | 4779 |
|
|
2016
Q1 | $24K | Sell |
2,200
-30,085
| -93% | -$328K | ﹤0.01% | 4734 |
|
|
2015
Q4 | $297K | Buy |
32,285
+29,301
| +982% | +$270K | ﹤0.01% | 3568 |
|
|
2015
Q3 | $20K | Sell |
2,984
-46,695
| -94% | -$313K | ﹤0.01% | 4984 |
|
|
2015
Q2 | $487K | Buy |
49,679
+1,532
| +3% | +$15K | ﹤0.01% | 3168 |
|
|
2015
Q1 | $427K | Buy |
48,147
+46,347
| +2,575% | +$411K | ﹤0.01% | 3233 |
|
|
2014
Q4 | $16K | Sell |
1,800
-200
| -10% | -$1.78K | ﹤0.01% | 4887 |
|
|
2014
Q3 | $14K | Sell |
2,000
-1,500
| -43% | -$10.5K | ﹤0.01% | 4835 |
|
|
2014
Q2 | $18K | Buy |
3,500
+1,000
| +40% | +$5.14K | ﹤0.01% | 4741 |
|
|
2014
Q1 | $11K | Buy |
2,500
+1,500
| +150% | +$6.6K | ﹤0.01% | 4867 |
|
|
2013
Q4 | $5K | Sell |
1,000
-19,688
| -95% | -$98.4K | ﹤0.01% | 4974 |
|
|
2013
Q3 | $105K | Buy |
20,688
+19,402
| +1,509% | +$98.5K | ﹤0.01% | 3910 |
|
|
2013
Q2 | $6K | Buy |
+1,286
| New | +$6K | ﹤0.01% | 4819 |
|